PMGC Holdings Inc
Research PMGC Holdings Inc (ELAB) on Bullrun: market cap USD 189.42K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerELAB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 189.42K
- Financial periodQ2 2026
- RevenueUSD 1.31M
- Net income-USD 2.94M
- Free cash flow-USD 1.96M
- Gross margin29.5%
Valuation Snapshot
latest market cap is USD 189.42K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 590.08K | -USD 7.75M | -USD 6.38M | 31.4% | -380.99 | USD 5.40M | USD 2.64M | USD 7.84M |
| FY2024 | USD 0 | -USD 6.25M | -USD 5.50M | n/a | -1195.13 | USD 3.98M | USD 0 | USD 6.66M |
| FY2023 | USD 1.71M | -USD 4.30M | -USD 4.57M | 66.2% | -0.4 | USD 3.33M | USD 210.49K | USD 3.83M |
| FY2022 | USD 766.28K | -USD 1.80M | -USD 1.62M | 58.4% | -0.19 | USD 1.15M | USD 283.22K | USD 1.13M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 189.42K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.87M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 7.02M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 21.55M | n/a | n/a | n/a |
About PMGC Holdings Inc
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PMGC Holdings Inc's market cap?
PMGC Holdings Inc's market capitalization is USD 189.42K.
What does PMGC Holdings Inc do?
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.